Faculty
Oncology Division

Kian-Huat Lim, MD, PhD
Associate Professor
Department of Medicine
Oncology Division
Molecular Oncology
Clinical Interests
- Pancreatic cancer
- Colon cancer
- Biliary cancer
- Neuroendocrine tumor
Research Interests
- Inflammation
- Innate immunity
- Immunotherapy
- Tumor-stroma interaction
- KRas
- IRAK4
Contact
- 314-747-7510 (office)
- 314-362-7009 (lab)
- 314-362-7086 (fax)
- kian-huat.lim@wustl.edu
- Division of Oncology
Mail Stop 8069-0012-05
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - Room 502 McDonnell Medical Sciences Building (lab)
- Lab website
Biosketch
Education | |
---|---|
1992-1999 | MD, National Taiwan University College of Medicine, Taipei, Taiwan |
2002-2006 | PhD, Molecular Cancer Biology Program, Duke University, Durham, NC |
Post-graduate Training | |
1999-2002 | Resident, Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan |
2007-2009 | Resident, Internal Medicine, Physician-Scientist Training Program, Washington University School of Medicine, Saint Louis, MO |
2009-2010 | Fellow, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
2010-2013 | Fellow, Medical Oncology Branch, NCI/NIH, Bethesda, MD |
Academic Positions | |
2013-2020 | Assistant Professor, Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
2020-present | Associate Professor, Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
University & Hospital Appointments & Committees | |
2013-present | Member, Siteman Cancer Center |
2013-present | Member, Division of Biology and Biomedical Sciences |
2013-present | Member, Institute of Clinical and Translational Sciences |
2019-present | Member, Cancer Biology Program Admission Committee |
2020-present | Director, Gastrointestinal Oncology Program, Siteman Cancer Center |
2020-present | Leader, Upper GI Focus Group, Siteman Cancer Center |
2021-present | Member, Siteman Cancer Center Strategic Planning Pancreas Workgroup |
2021-present | Reviewer, ICTS Just-in-time Award Review Panel, Washington University |
Board Certification | |
2011 | Diplomate, American Board of Internal Medicine |
2013 | Diplomate, American Board of Internal Medicine, Medical Oncology |
Honors & Awards | |
2002-2004 | Molecular Cancer Award, Duke University |
2004-2007 | Breast Cancer Research Program Predoctoral Award, US Department of Defense |
2006 | Outstanding Poster and Oral Presentation Award, Duke University Comprehensive Cancer Center |
2007 | Young Investigator Award, Duke University Comprehensive Cancer Center |
2012 | American Society of Hematology Abstract Achievement Award |
2013 | AACR-Bristol-Myers Squibb Oncology Scholar-in-Training Award |
2014 | Siteman Cancer Center Research Development Award |
2015 | Elsa Pardee Foundation Award |
2016 | AACR Pancreatic Cancer Action Network Career Development Award |
2016 | Siteman Cancer Center Pre-RO1 Award |
2016 | BJHF-ICTS Foundation Award |
2016 | Concern Foundation Conquer Cancer Now Award |
2016 | WUSTL SPORE Career Enhancement Award |
2018 | American Cancer Society Research Scholar Award |
Editorial Responsibilities | |
2015 | Guest Editor, Journal of Gastrointestinal Oncology |
National Scientific Panels | |
2015-2018 | Scientific Review Panel, Department of Defense PRCRP/CDMRP |
2016-present | Review Panel, BJHF-ICTS Grant |
2017-present | Review Panel, Siteman Investment Program |
2017 | Scientific Review Committee, Pancreatic Cancer Action Network, NCI Frederick National Laboratory for Cancer Research KRAS Fellowship |
2018-present | Ad hoc Reviewer, NIH/NCI Developmental Therapeutics Study Section |
2018 | Scientific Review Committee, Pancreatic Cancer Action Network Catalyst Grant |
2018-present | Ad hoc Reviewer, Pancreatic Cancer UK |
2019-present | NCI’s Pancreatic Cancer Microenvironment Network, Associate Member |
2020 | Scientific Review Committee, Pancreatic Cancer Action Network Translational Research Grant |
2020 | Principal Investigator (Wash U), PanCan Precision Promise Clinical Trial Consortium |
2021-present | Ad hoc Reviewer, NCI R03/R21 Omnibus Clinical and Translational Cancer Research Panel |
Professional Societies | |
2003-present | American Association for Cancer Research |
2009-present | American Society of Clinical Oncology |